Welcome to LookChem.com Sign In|Join Free
  • or
1-bromo-4-phenethoxybenzene is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

30752-27-3

Post Buying Request

30752-27-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

30752-27-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 30752-27-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,0,7,5 and 2 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 30752-27:
(7*3)+(6*0)+(5*7)+(4*5)+(3*2)+(2*2)+(1*7)=93
93 % 10 = 3
So 30752-27-3 is a valid CAS Registry Number.

30752-27-3Downstream Products

30752-27-3Relevant academic research and scientific papers

Cleavage of ethers in an ionic liquid. Enhancement, selectivity and potential application

Hart, William E. S.,Aldous, Leigh,Harper, Jason B.

, p. 5556 - 5563 (2017)

The cleavage of a series of ethers was examined in an ionic liquid containing hydrogen bromide. Reactions that did not proceed in either water or DMSO were found to proceed readily in this system, with notable selectivity between the cleavage of the different ether types examined herein. Increasing the proportion of water in the reaction mixture dramatically decreased the rate constant of ether cleavage; this could, in part, be attributed to a decrease in the solvent stabilisation of the transition state. Through analysis of the electronic requirements of the reaction (using substrates containing substituents with different Hammett parameters) and observation of rate enhancements for an ortho substituted system, the importance of the extent of protonation of the ether prior to nucleophilic attack was demonstrated.

PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

-

Page/Page column 70; 71, (2018/08/04)

Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS. (I)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 30752-27-3